Valeo SE (LON:0RH5)
 11.99
 -0.26 (-2.08%)
  At close: Oct 31, 2025
Valeo SE Revenue
Valeo SE had revenue of 10.66B EUR in the half year ending June 30, 2025, a decrease of -4.92%. This brings the company's revenue in the last twelve months to 21.04B, down -4.16% year-over-year. In the year 2024, Valeo SE had annual revenue of 21.49B, down -2.50%.
Revenue (ttm) 
 21.04B EUR
Revenue Growth 
 -4.16%
P/S Ratio 
 0.15
Revenue / Employee 
 198.26K EUR
Employees 
 106,100
Market Cap 
2.64B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 21.49B | -552.00M | -2.50% | 
| Dec 31, 2023 | 22.04B | 2.01B | 10.02% | 
| Dec 31, 2022 | 20.04B | 2.78B | 16.08% | 
| Dec 31, 2021 | 17.26B | 826.00M | 5.03% | 
| Dec 31, 2020 | 16.44B | -3.04B | -15.61% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Shell | 200.18B | 
| BP p.l.c. | 134.89B | 
| Unilever | 51.24B | 
| HSBC Holdings | 43.13B | 
| AstraZeneca | 41.24B | 
| Rio Tinto Group | 39.22B | 
| GSK plc | 32.17B | 
| British American Tobacco p.l.c. | 25.60B |